OBJECT: The purpose of this study was to analyze the relationship of axial diffusivity (AD) and radial diffusivity (RD) in peritumoral edema of high grade glioma, metastasis, and meningioma, and to differentiate tumor-infiltrated edema from pure vasogenic edema. MATERIALS AND METHODS: Twenty patients with high-grade glioma and 16 with meningioma or metastatic tumor were enrolled in our study. All cases were confirmed by histopathological study. Diffusion tensor imaging (DTI) was performed in all patients. Peritumoral edema of high-grade glioma was considered tumor-infiltrated edema, and edema of meningioma or metastasis was considered pure vasogenic edema. Fractional anisotropy (FA), mean diffusivity (MD), AD, RD, regression coefficient of RD to AD (RCRD-AD), and tumor infiltration index (TII) in tumor-infiltrated edema and pure vasogenic edema were analyzed and compared. Receiver operating characteristic (ROC) curve analysis was conducted to demonstrate their differential effectiveness. RESULTS: RCRD-AD in tumor-infiltrated edema (0.724±0.125) was significantly higher than that in pure vasogenic edema (0.571±0.111) (P=0.001). FA of tumor-infiltrated edema (0.175±0.025) was significantly lower than that of pure vasogenic edema (0.203±0.035) (P=0.007). Other parameters showed no significant difference between the 2 types of edema. ROC curve analysis showed RCRD-AD was the most effective parameter in distinguishing tumor-infiltrated edema from pure vasogenic edema. Using a threshold of 0.6, a sensitivity of 0.85 and specificity of 0.69 can be achieved with RCRD-AD. CONCLUSION: Analysis of the AD and RD relationship may reflect differences in diffusion characteristics of edema surrounding high-grade glioma and meningioma or metastasis, and may be helpful in detecting peritumoral infiltration in high-grade glioma.
OBJECT: The purpose of this study was to analyze the relationship of axial diffusivity (AD) and radial diffusivity (RD) in peritumoral edema of high grade glioma, metastasis, and meningioma, and to differentiate tumor-infiltrated edema from pure vasogenic edema. MATERIALS AND METHODS: Twenty patients with high-grade glioma and 16 with meningioma or metastatic tumor were enrolled in our study. All cases were confirmed by histopathological study. Diffusion tensor imaging (DTI) was performed in all patients. Peritumoral edema of high-grade glioma was considered tumor-infiltrated edema, and edema of meningioma or metastasis was considered pure vasogenic edema. Fractional anisotropy (FA), mean diffusivity (MD), AD, RD, regression coefficient of RD to AD (RCRD-AD), and tumor infiltration index (TII) in tumor-infiltrated edema and pure vasogenic edema were analyzed and compared. Receiver operating characteristic (ROC) curve analysis was conducted to demonstrate their differential effectiveness. RESULTS:RCRD-AD in tumor-infiltrated edema (0.724±0.125) was significantly higher than that in pure vasogenic edema (0.571±0.111) (P=0.001). FA of tumor-infiltrated edema (0.175±0.025) was significantly lower than that of pure vasogenic edema (0.203±0.035) (P=0.007). Other parameters showed no significant difference between the 2 types of edema. ROC curve analysis showed RCRD-AD was the most effective parameter in distinguishing tumor-infiltrated edema from pure vasogenic edema. Using a threshold of 0.6, a sensitivity of 0.85 and specificity of 0.69 can be achieved with RCRD-AD. CONCLUSION: Analysis of the AD and RD relationship may reflect differences in diffusion characteristics of edema surrounding high-grade glioma and meningioma or metastasis, and may be helpful in detecting peritumoral infiltration in high-grade glioma.
Authors: Jean-Michel Lemée; Anne Clavreul; Marc Aubry; Emmanuelle Com; Marie de Tayrac; Pierre-Antoine Eliat; Cécile Henry; Audrey Rousseau; Jean Mosser; Philippe Menei Journal: J Neurooncol Date: 2015-01-06 Impact factor: 4.130
Authors: Theo Demerath; Carl Philipp Simon-Gabriel; Elias Kellner; Ralf Schwarzwald; Thomas Lange; Dieter Henrik Heiland; Peter Reinacher; Ori Staszewski; Hansjörg Mast; Valerij G Kiselev; Karl Egger; Horst Urbach; Astrid Weyerbrock; Irina Mader Journal: Neuroradiol J Date: 2016-11-19
Authors: C Badve; A Yu; S Dastmalchian; M Rogers; D Ma; Y Jiang; S Margevicius; S Pahwa; Z Lu; M Schluchter; J Sunshine; M Griswold; A Sloan; V Gulani Journal: AJNR Am J Neuroradiol Date: 2016-12-29 Impact factor: 3.825
Authors: Friso W A Hoefnagels; Philip De Witt Hamer; Ernesto Sanz-Arigita; Sander Idema; Joost P A Kuijer; Petra J W Pouwels; Frederik Barkhof; W Peter Vandertop Journal: J Neurooncol Date: 2014-07-31 Impact factor: 4.130
Authors: Carolin Weiss; Irada Tursunova; Volker Neuschmelting; Hannah Lockau; Charlotte Nettekoven; Ana-Maria Oros-Peusquens; Gabriele Stoffels; Anne K Rehme; Andrea Maria Faymonville; N Jon Shah; Karl Josef Langen; Roland Goldbrunner; Christian Grefkes Journal: Neuroimage Clin Date: 2015-01-20 Impact factor: 4.881
Authors: Carolin Weiss Lucas; Irada Tursunova; Volker Neuschmelting; Charlotte Nettekoven; Ana-Maria Oros-Peusquens; Gabriele Stoffels; Andrea Maria Faymonville; Shah N Jon; Karl Josef Langen; Hannah Lockau; Roland Goldbrunner; Christian Grefkes Journal: Neuroimage Clin Date: 2016-11-23 Impact factor: 4.881
Authors: Kevin S Holly; Benjamin J Barker; Derrick Murcia; Rebekah Bennett; Piyush Kalakoti; Christina Ledbetter; Eduardo Gonzalez-Toledo; Anil Nanda; Hai Sun Journal: Front Surg Date: 2017-04-10